BTIG Reiterates Buy on Verastem, Maintains $18 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.3%

Neg 0% Neu 87.3% Pos 0%

BTIG analyst Jeet Mukherjee reiterates Verastem (NASDAQ:VSTM) with a Buy and maintains $18 price target.

Comments

No comments yet. Be the first!